# Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

> **NCT02849145** · NA · COMPLETED · sponsor: **Institut Curie** · enrollment: 60 (actual)

## Conditions studied

- Uveal Melanoma

## Interventions

- **BIOLOGICAL:** Blood sampling

## Key facts

- **NCT ID:** NCT02849145
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-02-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02849145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02849145, "Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02849145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*